Overview

Significant class action cases involving different types of FDA-regulated products have been prevalent in the past several years. This webinar will discuss recent trends in class action litigation, including jurisdictions in which actions are most frequently filed, common claims theories, and settlement strategies. Speakers will also discuss how recent amendments to Rule 23 of the Federal Rules of Civil Procedure could affect litigation strategy, the evolving standard of ascertainability in addressing class certification, and damages models. Finally, we will look at the future of class actions for FDA-regulated products.

Get Access

$99
  • +$100 for nonmembers

Speakers

Anthony Anscombe, Partner, Steptoe & Johnson LLP
August Horvath, Partner, Foley Hoag LLP
William Janssen, Professor of Law, Charleston School of Law
Glenn Lammi, Chief Counsel, Legal Studies Division, Washington Legal Foundation

On-demand webinar recordings are sent via email as soon as we are able to process and verify your order. This usually occurs within 1 business day of your purchase.

On-demand content can be played back on most devices.

If you have concerns, please click the Test Your System link to determine your device’s compatibility, as well as system requirements.